Sinovac begins the construction of its first plant in Latin America in Chile

The plant, with a surface area of ​​22,000 meters, will package vials against covid-19, hepatitis A and influenza, biochemist Virginia Garretón, vice president of corporate affairs at Sinovac Biotech Chile, told Efe.

RIO DE JANEIRO, BRAZIL - The Chinese biopharmaceutical Sinovac Biotech, manufacturer of one of the most administered vaccines against covid-19 in several Latin American countries, began the construction of its first packaging plant in the region this Thursday in Santiago de Chile.

With a capacity to fill and package 50 million doses per year, the plant will be ready before 2023 and will require an investment of US$100 million, according to company sources at a massive opening ceremony.

Read also: Check out our coverage on Chile

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?